Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madalina V Nastase

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biochimica Et Biophysica Acta|February 11, 2014
Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiologyMadalina V Nastase, Renato V Iozzo, Liliana Schaefer
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 24, 2012
Biglycan: a multivalent proteoglycan providing structure and signalsMadalina V Nastase, Marian F Young, Liliana Schaefer
Advanced Drug Delivery Reviews|December 31, 2017
Targeting renal fibrosis: Mechanisms and drug delivery systemsMadalina V Nastase, Jinyang Zeng-Brouwers, Malgorzata Wygrecka, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 2, 2018
Danger-Associated Molecular Patterns Derived From the Extracellular Matrix Provide Temporal Control of Innate ImmunityCharles W Frevert, Jessica Felgenhauer, Malgorzata Wygrecka, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 2, 2018
Small Leucine-Rich Proteoglycans in Renal Inflammation: Two Sides of the CoinMadalina V Nastase, Andrea Janicova, Heiko Roedig, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|May 20, 2018
Biglycan is a new high-affinity ligand for CD14 in macrophagesHeiko Roedig, Madalina V Nastase, Helena Frey, et al.
Science Signaling|November 17, 2011
Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21Rosetta Merline, Kristin Moreth, Janet Beckmann, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta|February 11, 2014
Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiologyMadalina V Nastase, Renato V Iozzo, Liliana Schaefer
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 24, 2012
Biglycan: a multivalent proteoglycan providing structure and signalsMadalina V Nastase, Marian F Young, Liliana Schaefer
Advanced Drug Delivery Reviews|December 31, 2017
Targeting renal fibrosis: Mechanisms and drug delivery systemsMadalina V Nastase, Jinyang Zeng-Brouwers, Malgorzata Wygrecka, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 2, 2018
Danger-Associated Molecular Patterns Derived From the Extracellular Matrix Provide Temporal Control of Innate ImmunityCharles W Frevert, Jessica Felgenhauer, Malgorzata Wygrecka, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 2, 2018
Small Leucine-Rich Proteoglycans in Renal Inflammation: Two Sides of the CoinMadalina V Nastase, Andrea Janicova, Heiko Roedig, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|May 20, 2018
Biglycan is a new high-affinity ligand for CD14 in macrophagesHeiko Roedig, Madalina V Nastase, Helena Frey, et al.
Science Signaling|November 17, 2011
Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21Rosetta Merline, Kristin Moreth, Janet Beckmann, et al.
Pageof 1